KAMON; Takuma
Patent Applications and Registrations
Patent applications and USPTO patent grants for KAMON; Takuma.The latest application filed is for "pyrazolopyridine derivative having glp-1 receptor agonist effect".
- KAMON; Takuma - Shizuoka JP
- Kamon; Takuma - Osaka JP
| Patent | Date |
|---|---|
| Pyrazolopyridine Derivative Having Glp-1 Receptor Agonist Effect App 20210017176 - YOSHINO; Hitoshi ; et al. | 2021-01-21 |
| Pyrazolopyridine derivative having GLP-1 receptor agonist effect Grant 10,858,356 - Yoshino , et al. December 8, 2 | 2020-12-08 |
| Pyrazolopyridine Derivative Having Glp-1 Receptor Agonist Effect App 20190225604 - YOSHINO; Hitoshi ; et al. | 2019-07-25 |
| Substituted imidazo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines and oxazolo[4',5':4,5]cyclopenta[1,2-e]pyrrolo[1,2-a]pyrazines for treating brain cancer Grant 9,464,093 - Tun , et al. October 11, 2 | 2016-10-11 |
| Treating Brain Cancer using Agelastatin A (AA) and Analogues Thereof App 20150274742 - Tun; Han W. ; et al. | 2015-10-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 